Harvey J. Brandwein
Keine laufenden Positionen mehr
Profil
Harvey J.
Brandwein served as Director, Chief Technology Officer & SVP-Research at IRX Therapeutics, Inc. and Vice President-Healthcare Applications at Pall Corp.
He also served as Vice President at Genetic Diagnostics Corp.
from 1981 to 1988.
Brandwein holds a doctorate degree from the University of Connecticut, which he received in 1979, and an undergraduate degree from the State University of New York at Binghamton.
Ehemalige bekannte Positionen von Harvey J. Brandwein
| Unternehmen | Position | Ende |
|---|---|---|
Genetic Diagnostics Corp.
 Genetic Diagnostics Corp. BiotechnologyHealth Technology Genetic Diagnostics Corp. operates as a diagnostic imaging center. The company is headquartered in Great Neck, NY. | Corporate Officer/Principal | 01.01.1988 |
| PALL CORPORATION | Corporate Officer/Principal | - |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Harvey J. Brandwein
| University of Connecticut | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | Health Technology |
Genetic Diagnostics Corp.
Genetic Diagnostics Corp. BiotechnologyHealth Technology Genetic Diagnostics Corp. operates as a diagnostic imaging center. The company is headquartered in Great Neck, NY. | Health Technology |
